“…In historic series on cohorts treating nasal vestibule tumors with conventional RT or brachytherapy, local control and overall survival rates range from 67% to 92% and 50% to 90%, respectively [2,4,6,14]. The largest series of the DAHANCA study group including 174 patients with nasal vestibule cancer reports a local control rate and an overall survival rate of 67% and 50% at 5 years, respectively [14] (Table 3).…”